Literature DB >> 12795469

Effects on cell proliferation, activator protein-1 and genotoxicity by fecal water from patients with colorectal adenomas.

M M Nordling1, B Glinghammar, P C Karlsson, T M C M de Kok, J J Rafter.   

Abstract

BACKGROUND: The free water phase of feces (fecal water) may mediate the effects of diet on colon carcinogenesis. We examined the effects of fecal water from adenoma patients and controls on three parameters in colonocytes believed to be relevant to tumorigenesis, i.e. genotoxicity in intact cells and on isolated DNA, proliferative activity and activator protein-1 (AP-1) activity.
METHODS: Genotoxicity in intact colonic cells was assayed using the single-cell gel electrophoresis assay ('comet' assay) and on isolated DNA using double-stranded DNA from the X-174 RF plasmid. Cell proliferation was assessed using the commercially available 'alamar blue' proliferation kit and AP-1 activity using cells transiently transfected with an AP-1-luciferase reporter construct.
RESULTS: The data showed that lipid extracts of fecal water samples from the adenoma patients had a significantly higher capacity to induce cell proliferation than those from controls, and that this effect could be explained to a large extent by the concentrations of deoxycholic and chenodeoxycholic acids in the fecal water using regression models. No difference between patients and controls was observed for induction of AP-1 activity or induction of DNA strand breaks in intact cells. However, induction of DNA strand breaks in isolated DNA was significantly higher for the fecal waters from patients than for those from controls, which could be explained in part in a regression model by concentrations of lithocholic acid in fecal water and fecapentaene-12 in feces.
CONCLUSIONS: Our results support the hypothesis that the biochemistry of fecal waters from adenoma patients and controls differs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12795469

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

1.  Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis.

Authors:  Betsy C Wertheim; Jeffrey W Smith; Changming Fang; David S Alberts; Peter Lance; Patricia A Thompson
Journal:  Cancer Prev Res (Phila)       Date:  2011-11-04

2.  Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients.

Authors:  Patricia A Thompson; Betsy C Wertheim; Denise J Roe; Erin L Ashbeck; Elizabeth T Jacobs; Peter Lance; María Elena Martínez; David S Alberts
Journal:  Cancer Prev Res (Phila)       Date:  2009-12-01

Review 3.  Approaches that ascertain the role of dietary compounds in colonic cancer cells.

Authors:  Michael Bordonaro; Koen Venema; Adeline K Putri; Darina Lazarova
Journal:  World J Gastrointest Oncol       Date:  2014-01-15

4.  Physical activity as a determinant of fecal bile acid levels.

Authors:  Betsy C Wertheim; María Elena Martínez; Erin L Ashbeck; Denise J Roe; Elizabeth T Jacobs; David S Alberts; Patricia A Thompson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-04-21       Impact factor: 4.254

Review 5.  Current concepts in colorectal cancer prevention.

Authors:  Patricia A Thompson; Eugene W Gerner
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2009-08       Impact factor: 3.869

6.  Recent Perspectives on the Relations between Fecal Mutagenicity, Genotoxicity, and Diet.

Authors:  Silvia W Gratz; R John Wallace; Hani S El-Nezami
Journal:  Front Pharmacol       Date:  2011-03-03       Impact factor: 5.810

Review 7.  Towards microbial fermentation metabolites as markers for health benefits of prebiotics.

Authors:  Kristin A Verbeke; Alan R Boobis; Alessandro Chiodini; Christine A Edwards; Anne Franck; Michiel Kleerebezem; Arjen Nauta; Jeroen Raes; Eric A F van Tol; Kieran M Tuohy
Journal:  Nutr Res Rev       Date:  2015-06       Impact factor: 7.800

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.